Compounds fend off Alzheimer's disease amyloid pathology


A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease.


[ Terug naar het hoofdmenu ]